Showing results (21-30 of 34) with videos related to
Sort By:
Pageof 4
Hormones and Behavior|September 13, 2011
Androgens exacerbate motor asymmetry in male rats with unilateral 6-hydroxydopamine lesionRebecca L Cunningham, Teresa Macheda, Lora Talley Watts, et al.Molecular and Cellular Neurosciences|May 7, 2011
Insulin-like growth factor-I mediates neuroprotection in proteasome inhibition-induced cytotoxicity in SH-SY5Y cellsBenxu Cheng, Shivani Kaushal Maffi, Alex Anthony Martinez, et al.Journal of Neurochemistry|January 26, 2007
CB1-independent inhibition of dopamine transporter activity by cannabinoids in mouse dorsal striatumDavid A Price, William A Owens, Georgianna G Gould, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|June 10, 2010
Macrophage-mediated GDNF delivery protects against dopaminergic neurodegeneration: a therapeutic strategy for Parkinson's diseaseKc Biju, Qing Zhou, Guiming Li, et al.Journal of Neurochemistry|March 7, 2006
Modulation of bradykinin signaling by EP24.15 and EP24.16 in cultured trigeminal gangliaNathaniel A Jeske, Kelly A Berg, Joanne C Cousins, et al.The Journal of Pharmacology and Experimental Therapeutics|July 22, 2010
17beta-estradiol rapidly enhances bradykinin signaling in primary sensory neurons in vitro and in vivoMatthew P Rowan, Kelly A Berg, Stephen B Milam, et al.The Journal of Biological Chemistry|June 6, 2006
Fine tuning PDK1 activity by phosphorylation at Ser163Ramon A Riojas, Chintan K Kikani, Changhua Wang, et al.The European Journal of Neuroscience|June 4, 2009
WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's diseaseDavid A Price, Alex A Martinez, Alexandre Seillier, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 7, 2011
Novel regulation of parkin function through c-Abl-mediated tyrosine phosphorylation: implications for Parkinson's diseaseSyed Z Imam, Qing Zhou, Ayako Yamamoto, et al.Neuroscience Letters|January 9, 2013
Bone marrow-derived microglia-based neurturin delivery protects against dopaminergic neurodegeneration in a mouse model of Parkinson's diseaseK C Biju, Rene A Santacruz, Cang Chen, et al.Pageof 4